Abeona Therapeutics Inc. (ABEO) Financials
ABEO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 64.0 million | 49.2 million |
2023-09-30 | 66.1 million | 44.0 million |
2023-06-30 | 53.6 million | 44.2 million |
2023-03-31 | 53.3 million | 34.6 million |
ABEO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -9.3 million | 1.5 million |
2023-09-30 | -5.8 million | 1.6 million |
2023-06-30 | -10.3 million | 927000 |
2023-03-31 | -12.0 million | 770000 |
ABEO Net Income
No data available :(
ABEO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 52.6 million | - | 5.4 million |
2023-09-30 | 53.8 million | - | 5.7 million |
2023-06-30 | 36.8 million | - | 6.0 million |
2023-03-31 | 40.4 million | - | 7.3 million |
ABEO Shares Outstanding
ABEO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 37000 | 7.4 million | 5.8 million | - |
2023-09-30 | 44000 | 7.1 million | 4.2 million | - |
2023-06-30 | 32000 | 8.5 million | 5.0 million | - |
2023-03-31 | 218000 | 8.0 million | 4.0 million | - |
ABEO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 721000 |
2023-09-30 | - | 751000 |
2023-06-30 | 3.5 million | 838000 |
2023-03-31 | - | 888000 |
ABEO
Price: $4.60
52 week price:
Earnings Per Share: -2.53 USD
P/E Ratio: -3.23
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 254600
Ebitda: -5.2 millionMarket Capitalization: 203.5 million